| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M301344200 |
| P698 | PubMed publication ID | 12764129 |
| P50 | author | Michael J. Matunis | Q42788903 |
| P2093 | author name string | Curt M Horvath | |
| Richard S Rogers | |||
| P2860 | cites work | Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction | Q22254071 |
| A transcriptional corepressor of Stat1 with an essential LXXLL signature motif | Q24290918 | ||
| The role of STATs in apoptosis | Q24301148 | ||
| Identification of a nuclear Stat1 protein tyrosine phosphatase | Q24302061 | ||
| Inhibition of Stat1-mediated gene activation by PIAS1 | Q24310082 | ||
| Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA | Q24336371 | ||
| Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity | Q24531180 | ||
| Transcription factor Sp3 is silenced through SUMO modification by PIAS1 | Q24534887 | ||
| PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies | Q24599898 | ||
| Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development | Q24793150 | ||
| Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1 | Q27637899 | ||
| An E3-like factor that promotes SUMO conjugation to the yeast septins | Q28188846 | ||
| Involvement of PIAS1 in the sumoylation of tumor suppressor p53 | Q28189956 | ||
| A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3 | Q28201630 | ||
| Signaling through the JAK/STAT pathway, recent advances and future challenges | Q28201804 | ||
| PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1 | Q28208433 | ||
| PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription | Q28217862 | ||
| Specific Inhibition of Stat3 Signal Transduction by PIAS3 | Q28255665 | ||
| Stats: transcriptional control and biological impact | Q29547776 | ||
| SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting | Q29619527 | ||
| SUMO--nonclassical ubiquitin | Q29620234 | ||
| Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). | Q35836715 | ||
| Induction of the Ly-6A/E gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds | Q36432406 | ||
| A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy | Q39454884 | ||
| PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. | Q39695522 | ||
| The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification | Q43548130 | ||
| Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. | Q44279178 | ||
| Potentiation of glucocorticoid receptor transcriptional activity by sumoylation | Q51843778 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 30091-30097 | |
| P577 | publication date | 2003-05-22 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation | |
| P478 | volume | 278 |
| Q39927831 | A conserved catalytic residue in the ubiquitin-conjugating enzyme family. |
| Q28271534 | A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes |
| Q34551874 | A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells |
| Q38313567 | A novel repressor domain is required for maximal growth inhibition by the IRF-1 tumor suppressor |
| Q35140327 | Adenovirus Sequesters Phosphorylated STAT1 at Viral Replication Centers and Inhibits STAT Dephosphorylation |
| Q80622021 | Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma |
| Q51939364 | Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software |
| Q39797415 | BS69 undergoes SUMO modification and plays an inhibitory role in muscle and neuronal differentiation |
| Q37146441 | Biology and significance of the JAK/STAT signalling pathways |
| Q39128976 | Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses |
| Q34876834 | Cloning the human SUMO1 promoter |
| Q51816792 | Cobalt Protoporphyrin Upregulates Cyclooxygenase-2 Expression Through a Heme Oxygenase-Independent Mechanism |
| Q42737623 | Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO). |
| Q24644027 | DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells |
| Q33316416 | Differential regulation of the two transcriptional activation domains of the coiled-coil coactivator CoCoA by sumoylation |
| Q35376317 | Dysregulation of janus kinases and signal transducers and activators of transcription in cancer |
| Q28475642 | Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery |
| Q43357710 | Effects of Sijunzi decoction and Yupingfeng powder on expression of janus kinase-signal transducer and activator of transcription signal pathway in the brain of spleen-deficiency model rats |
| Q42616973 | Evidence for a functional link between Dd-STATa and Dd-PIAS, a Dictyostelium PIAS homologue |
| Q30445485 | Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells |
| Q26314693 | Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention |
| Q25257455 | Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene |
| Q50036802 | Global Identification of Small Ubiquitin-related Modifier (SUMO) Substrates Reveals Crosstalk between SUMOylation and Phosphorylation Promotes Cell Migration. |
| Q38603654 | HCV infection, IFN response and the coding and non-coding host cell genome |
| Q50631183 | Identification of gene variants associated with hypoxia pathway in acute coronary syndrome: a pilot study |
| Q36480563 | Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7) |
| Q52319726 | Interferon Independent Non-Canonical STAT Activation and Virus Induced Inflammation. |
| Q34405609 | Interferon-stimulated genes: a complex web of host defenses |
| Q47221276 | Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism |
| Q42909663 | Mimosa: mixture model of co-expression to detect modulators of regulatory interaction |
| Q34828184 | Modification of the erythroid transcription factor GATA-1 by SUMO-1. |
| Q40318695 | Modulation of the activation of Stat1 by the interferon-gamma receptor complex |
| Q42355514 | Multiple Functions of Protein Inhibitor of Activated STAT1 in Regulating Endothelial Cell Proliferation and Inflammation |
| Q36060432 | Multisite protein modification and intramolecular signaling |
| Q39890149 | Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation |
| Q55264672 | On the role of STAT1 and STAT6 ADP-ribosylation in the regulation of macrophage activation. |
| Q24559766 | PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73 |
| Q46006991 | PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. |
| Q35128090 | PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus |
| Q36105975 | PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. |
| Q39366507 | PIASx acts as an Elk-1 coactivator by facilitating derepression |
| Q24293208 | PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia |
| Q39896633 | PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling |
| Q37823682 | Phosphorylation meets nuclear import: a review |
| Q40404178 | Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani |
| Q40622102 | Protective effect of epigallocatechin-3-gallate on ischemia/reperfusion-induced injuries in the heart: STAT1 silencing flavonoid. |
| Q40483986 | Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. |
| Q35605437 | Regulation of JAK-STAT signalling in the immune system |
| Q47930961 | Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1. |
| Q28297056 | Regulation of cytokine signaling pathways by PIAS proteins |
| Q28264801 | Regulation of gene-activation pathways by PIAS proteins in the immune system |
| Q39376971 | Responses to Cytokines and Interferons that Depend upon JAKs and STATs |
| Q28611538 | SUMO modification of heterogeneous nuclear ribonucleoproteins |
| Q28243200 | SUMO wrestling with type 1 diabetes |
| Q35714635 | SUMO-Specific Protease 1 Is Critical for Early Lymphoid Development through Regulation of STAT5 Activation |
| Q36471374 | SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy |
| Q34008085 | SUMO4 and its role in type 1 diabetes pathogenesis |
| Q35691533 | SUMO: a regulator of gene expression and genome integrity. |
| Q36048656 | Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. |
| Q37859135 | Signal transducers and activators of transcription—from cytokine signalling to cancer biology |
| Q37392596 | Small ubiquitin-like modifiers in cellular malignancy and metastasis |
| Q40252886 | Stat1 and SUMO modification |
| Q34435881 | Structure-function analysis indicates that sumoylation modulates DNA-binding activity of STAT1. |
| Q38961119 | Sumoylation Modulates the Susceptibility to Type 1 Diabetes. |
| Q37241502 | Targeting the PIAS1 SUMO ligase pathway to control inflammation |
| Q38337410 | The logic of communication: roles for mobile transcription factors in plants |
| Q39388632 | The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. |
| Q28181614 | The ‘PINIT’ motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L |
| Q40559915 | Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification |
Search more.